Africa: Johnson & Johnson Must Halve Price of Lifesaving TB Drug Bedaquiline

[MSF] Médecins Sans Frontières (MSF) has launched a global campaign calling on pharmaceutical corporation Johnson & Johnson (J&J) to lower the price of its anti-tuberculosis medicine bedaquiline to no more than US$1 per day for people everywhere who need it, in order to allow scale-up of drug-resistant tuberculosis (DR-TB) treatment and reduce deaths.


Continue reading:  

Africa: Johnson & Johnson Must Halve Price of Lifesaving TB Drug Bedaquiline

Comments are closed.